• Home
  •  / Cronos Group

Cronos Group

OverviewSuggest Edit

The Cronos Group (formerly known as PharmaCan Capital) is a global cannabinoid company that distributes medical cannabis products. The company also engages in cannabis research, technology, and product development. Its product portfolio includes PEACE NATURALS, a global wellness platform, COVE and Spinach, adult-use brands, as well as Lord Jones and PEACE, hemp-derived cannabidiol (CBD) brands.

TypePublic
Founded2013
HQToronto, CAMap
Websitethecronosgroup.com
View Jobs (33)

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2019)631(+1606%)
Job Openings33
Revenue (FY, 2019)$23.8 M(+52%)
Share Price (Nov 2020)$7.4 (+4%)
Cybersecurity ratingCMore

Key People/Management at Cronos Group

Mike Gorenstein

Mike Gorenstein

Executive Chairman
Jerry Barbato

Jerry Barbato

CFO
Todd K. Abraham

Todd K. Abraham

Chief Innovation Officer
Jim Rudyk

Jim Rudyk

Lead Director, Audit Committee Chair
Kurt Schmidt

Kurt Schmidt

President & Chief Executive Officer
Show more

Cronos Group Office Locations

Cronos Group has offices in Toronto, Melbourne and Gan Shmuel
Toronto, CA (HQ)
320-720 King St W
Melbourne, AU
PO Box 24286
Gan Shmuel, IL
POB 578
Show all (3)

Cronos Group Financials and Metrics

Cronos Group Revenue

Cronos Group's revenue was reported to be $23.75 m in FY, 2019 which is a 51.2% increase from the previous period.
USD

Revenue (FY, 2019)

23.8m

Revenue growth (FY, 2018 - FY, 2019), %

51.2%

Gross profit (FY, 2019)

(17.9m)

Gross profit margin (FY, 2019), %

(75.2%)

Net income (FY, 2019)

1.2b

EBIT (FY, 2019)

(121.5m)

Market capitalization (17-Nov-2020)

2.6b

Closing stock price (17-Nov-2020)

7.4

Cash (31-Dec-2019)

1.2b

EV

1.4b
Cronos Group's current market capitalization is $2.6 b.
Annual
CADFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

554.2k4.1m15.7m23.8m

Revenue growth, %

637%285%51%

Cost of goods sold

4.4m41.6m

Gross profit

11.3m(17.9m)
Quarterly
CADQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

513.8k643.7k1.3m2.9m3.4m3.8m4.0m10.2m7.6m

Cost of goods sold

1.0m1.7m4.3m9.5m

Gross profit

1.9m2.1m5.9m(1.9m)

Gross profit Margin, %

65%56%58%(25%)
show all
Annual
CADFY, 2016FY, 2017FY, 2018FY, 2019

Cash

3.5m9.2m32.6m1.2b

Accounts Receivable

107.2k1.1m4.2m4.6m

Prepaid Expenses

503.2k790.0k3.9m9.4m

Inventories

1.9m8.4m11.6m38.0m
Quarterly
CADQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

15.2m4.4m16.5m32.4m89.6m41.5m2.4b1.6b1.5b

Accounts Receivable

243.1k298.1k399.9k2.5m2.8m3.3m2.8m9.2m6.9m

Prepaid Expenses

568.0k2.7m2.2m4.7m4.1m10.2m5.1m7.1m11.7m

Inventories

2.3m2.7m4.8m9.0m12.3m15.1m25.1m41.6m54.1m
show all
Annual
CADFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(1.2m)2.5m(19.2m)1.2b

Depreciation and Amortization

382.7k996.0k2.5m3.9m

Inventories

(714.1k)(6.5m)(11.5m)(51.9m)

Accounts Payable

6.7m7.5m13.3m
Quarterly
CADQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Net Income

(844.4k)(669.6k)427.9k(1.0m)(327.0k)(6.7m)428.0m678.9m1.5b

Depreciation and Amortization

200.6k428.9k684.0k540.0k1.1m1.8m470.0k1.1m2.1m

Inventories

(351.1k)(804.8k)(2.9m)(598.0k)(8.7m)(13.0m)(15.8m)(35.8m)(62.3m)

Accounts Payable

73.0k208.5k3.5m(5.1m)(5.7m)(5.0m)26.6m12.3m36.4m
show all
USDFY, 2016

Financial Leverage

1.3 x
Show all financial metrics

Cronos Group Operating Metrics

FY, 2017FY, 2018FY, 2019

Brands

3 5

Dried Cannabis Varieties

21

Cannabis Oils Varieties

10

Cannabis Production Land (Peace Naturals), acres

90 90
Show all operating metrics

Cronos Group Acquisitions / Subsidiaries

Company NameDateDeal Size
Lord JonesAugust 02, 2019$300 m
Cronos Israel G.S. Cultivations Ltd
Cronos Israel G.S. Manufacturing Ltd.
Cronos Israel G.S. Pharmacies Ltd.
Cronos Israel G.S. Store Ltd

Cronos Group Revenue Breakdown

Embed Graph

Cronos Group revenue breakdown by business segment: 22.5% from Cannabis Extracts, 63.2% from Cannabis Flower and 14.3% from Other

Cronos Group revenue breakdown by geographic segment: 14.2% from United States and 85.8% from Rest of World

Cronos Group Cybersecurity Score

Cybersecurity ratingPremium dataset

C

74/100

Learn more about our premium products
SecurityScorecard logo

Cronos Group Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

Learn more about our premium products
CSRHub logo

Cronos Group Online and Social Media Presence

Cronos Group's Trends

Embed Graph

Cronos Group News and Updates

November 03, 2020

Thinking about buying stock in O2Micro International, Sasol Limited, 3D Systems, Cronos Group, or Sorrento Therapeutics?

NEW YORK, Nov. 3, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OIIM, SSL, DDD, CRON, and SRNE. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
October 23, 2020

Cronos Group Inc. to Hold 2020 Third Quarter Earnings Conference Call on November 5, 2020

TORONTO, Oct. 23, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2020 Third Quarter Earnings Conference Call on Thursday, November 5, 2020 at 8:30 a.m. EST. Cronos Group’s senior management team will discuss the Company’s finan…
October 14, 2020

Kristen Bell Launches Happy Dance™ CBD Brand with Cronos Group

New CBD skincare collection redefines self-care New CBD skincare collection redefines self-care
October 05, 2020

Cronos Group launches leading medical brand PEACE NATURALS™ in Israel

TORONTO and GAN SHMUEL, Israel, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) a global cannabinoid company, is pleased to announce the launch of its leading medical brand PEACE NATURALS™, in pharmacies throughout Israel through Cro…
September 15, 2020

Cronos Group Recognized by the Toronto Stock Exchange’s TSX30 Program

TORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that on September 15, 2020, the Company was recognized by the Toronto Stock Exchange as the third top-performing company on the Toronto Stock Exchange’s 2020 T…
September 14, 2020

Cronos Group Inc. to Present at the CIBC 19th Annual Eastern Institutional Investor Conference

TORONTO, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at the CIBC 19th Annual Eastern Institutional Investor Conferen…
Show more

 Cronos Group Frequently Asked Questions

  • When was Cronos Group founded?

    Cronos Group was founded in 2013.

  • Who are Cronos Group key executives?

    Cronos Group's key executives are Mike Gorenstein, Jerry Barbato and Todd K. Abraham.

  • How many employees does Cronos Group have?

    Cronos Group has 631 employees.

  • What is Cronos Group revenue?

    Latest Cronos Group annual revenue is $23.8 m.

  • What is Cronos Group revenue per employee?

    Latest Cronos Group revenue per employee is $37.6 k.

  • Who are Cronos Group competitors?

    Competitors of Cronos Group include Aphria, Auxly and Harvest One.

  • Where is Cronos Group headquarters?

    Cronos Group headquarters is located at 320-720 King St W, Toronto.

  • Where are Cronos Group offices?

    Cronos Group has offices in Toronto, Melbourne and Gan Shmuel.

  • How many offices does Cronos Group have?

    Cronos Group has 3 offices.